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Epilepsy is a common and serious neurological disorder characterized by occurrence
of recurrent spontaneous seizures, and emerging evidences support the association
of mitochondrial dysfunction with epilepsy. Sirtuin 5 (SIRT5), localized in mitochondrial
matrix, has been considered as an important functional modulator of mitochondria
that contributes to ageing and neurological diseases. Our data shows that SIRT5
deficiency strikingly increased mortality rate and severity of response to epileptic
seizures, dramatically exacerbated hippocampal neuronal loss and degeneration in mice
exposed to Kainate (KA), and triggered more severe reactive astrogliosis. We found
that the expression of mitochondrial SIRT5 of injured hippocampus was relatively up-
regulated, indicating its potential contribution to the comparably increased survival of
these cells and its possible neuroprotective role. Unexpectedly, SIRT5 seems not to
apparently alter the decline of antioxidant enzymes superoxide dismutase 2 (SOD2) and
glutathione peroxidase (GPx) in hippocampus caused by KA exposure in our paradigm,
which indicates the protective role of SIRT5 on seizures and cellular degeneration
might through different regulatory mechanism that would be explored in the future.
In the present study, we provided strong evidences for the first time to demonstrate
the association between SIRT5 and epilepsy, which offers a new understanding of the
roles of SIRT5 in mitochondrial functional regulation. The neuroprotection of SIRT5 in
KA-induced epileptic seizure and neurodegeneration will improve our current knowledge
of the nature of SIRT5 in central nervous system (CNS) and neurological diseases.
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INTRODUCTION
Epilepsy is a common and serious neurological disorder that affects about 50 million people
worldwide, characterized by the unpredictable but recurrent occurrence of spontaneous
seizures (Pitkanen and Lukasiuk, 2011). The cellular and molecular mechanisms of seizures
and epileptogenesis remain unknown. Recently, increasing evidences have been supporting the
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 June 2016 | Volume 10 | Article 171
Li and Liu SIRT5 Deficiency Enhances Seizure Susceptibility
association of mitochondrial dysfunction and oxidative stress
with epilepsy, not only as a consequence of epileptic seizures,
but also as a contributor in epileptogenesis (Kunz, 2002; Patel,
2004; Waldbaum and Patel, 2010a). Kainate (KA), an analog
of glutamate, is a 30-fold more potent neurotoxicant; and KA
exerts its neuro-excitotoxic and epileptogenic effects by acting on
glutamate receptors (Zaczek et al., 1981; Ferkany et al., 1984). The
KA-induced seizure model is widely used as a model of human
temporal lobe epilepsy (Ben-Ari and Cossart, 2000).
Mitochondrial dysfunction and oxidative stress have been
implicated in the pathogenesis of many neurodegenerative
diseases; however, their contribution to the development
of epilepsy is still unclear (Waldbaum and Patel, 2010b;
Rowley and Patel, 2013). Mitochondria have various pivotal
cellular functions including production of ATP, regulation
of intracellular Ca2+ signaling, and production of reactive
oxygen species (ROS), critically affecting neuronal excitability.
Functional defect of mitochondria has been observed in
human and animal epilepsy (Kunz et al., 2000). For example,
mitochondrial oxidative stress has been demonstrated to
be a contributing mechanism to epilepsy in mitochondrial
antioxidant (Sod2−/−) deficient mice that exhibited spontaneous
electrographic and motor seizures (Liang et al., 2012).
Experimental epileptic seizures have been reported to cause
acute oxidative damage to cellular macromolecules that
ultimately leads to neuronal death in susceptible brain
regions, but long-term effect of seizures on mitochondrial
defect and oxidative stress is still obscure (Kudin et al.,
2002).
Sirtuins are the family of nicotinamide adenine dinucleotide
(NAD+)-dependent histone deacetylases that modulate distinct
metabolic pathways, diverse stress responses and other biological
activities in metabolism, aging and other diseases (Michishita
et al., 2005). Sirtuin 5 (SIRT5), localized in mitochondrial
matrix, is mostly expressed in brain, heart, liver, muscle
and kidney (Mahlknecht et al., 2006; Schlicker et al., 2008).
Previous studies showed that SIRT5 regulates the urea cycle by
deacetylating and activating carbamoyl phosphate synthase 1
(CPS1; Nakagawa et al., 2009; Parihar et al., 2015). In addition
to its deacetylase activity, SIRT5 exhibits demalonylase and
desuccinylase activities (Du et al., 2011; Peng et al., 2011).
The effect of SIRT5 on mitochondrial metabolism and function
implies the potential positive correlation between SIRT5 and
epilepsy. However, till today, the effect and mechanism of SIRT5
in the regulation of mitochondrial biology, such as energy
production, metabolism and intracellular signaling in healthy
brain and neurological diseases are still poorly understood. No
report demonstrated the association of SIRT5 with epilepsy and
the contribution of SIRT5 in the pathogenesis of seizure and of
epilepsy.
Given the important role of SIRT5 in the functional
regulation of mitochondria and our previous study, we
hypothesized that SIRT5 is an important regulator in KA-
induced neurodegeneration and the underlying oxidative
stress. Accordingly, our study had three goals: (1) to
determine whether the lack of SIRT5 can increase the seizure
susceptibility and mortality by comparing SIRT5−/− and
wild-type (WT) mice exposed to KA; (2) to assess the effect
of SIRT5 deficiency on hippocampal neurodegeneration
and associated reactive astrogliosis; (3) to test whether KA
exposure can alter SIRT5 expression and thereby affect
mitochondrial antioxidant enzyme superoxide dismutase
2 (SOD2) and glutathione peroxidase (GPx) levels, which
might be involved in the underlying mechanism of above
neuroprotection. The present study will provide the evidence
for the important role of SIRT5 on KA-induced seizure and
epilepsy by using genetic ablation of SIRT5 in mice. Further
investigation is needed to better understand the underlying
mechanisms.
MATERIALS AND METHODS
Animals
Eight to 12 weeks old male mice were housed on a 12 h light/dark
cycle and allowed ad libitum access to food and water. SIRT5−/−
mice (n = 42) were purchased from Jackson laboratory. Age
matched WT male C57BL/6 mice (n = 38) were used as
controls. All animal procedures were performed in accordance
with National Institute of Health guidelines and approved by
Institutional Animal Care and the relevant Institutional Ethical
Review Committees.
Kainate Induced Seizure
Systemic injection of KA was used to investigate whether SIRT5
deficiency affected the behavioral seizures and the mortality
rate. KA (Sigma, St. Louis, MO, USA) solutions were freshly
prepared before use according to the manufacturer’s instruction.
KA was dissolved at a concentration 2 µg/µl in alkalized
isotonic saline. Adult mice were injected intraperitoneally
with a single dosage (either 20 mg/kg or a higher dose
of 25 mg/kg) of KA. KA-treated mice were evaluated every
20 min for 2 h after KA injection by trained experimenter
blind to genotype. The behavioral seizures were scored 0–5
according to reference descriptions (Ben-Ari et al., 1981;
Yang et al., 1997): 0, normal behavior; 1, immobilization,
‘‘wet-dog shakes’’ occasionally; 2, head nodding, unilateral
forelimb clonus, frequent ‘‘wet dog shaking’’; 3, rearing, bilateral
forelimb clonus; 4, generalized limbic seizures with falling and
running; 5, continuous generalized seizures with tonic limbic
extension, death. The survival rate was analyzed 24 h after KA
injection.
In addition to recording seizure scores, the severity of
seizures was calculated by integrating individual scores of
each mouse over the experiment period (Giménez-Cassina
et al., 2012). This method incorporates the seizure severity
of mice that died in 2 h following KA injection. Briefly,
all scores of same mouse were added together and then
divided by the total experimental time by using the formula:
Seizure Severity each mouse = ∑ (all scores of each
mouse)/experimental time. The mean value of the seizure
severity in WT mice group was set as 100%, which was
applied to normalize the value of tested genotype within the
same scale.
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Histology and Immunohistochemistry
For preparation of brain sections, mice treated with KA (20
mg/kg, 2 mg/ml) or Saline were deeply anesthetized with
isoflurane and sacrificed, then perfused transcardially with
phosphate buffered saline (PBS, 150 mM NaCl, 10 mM
Na-phosphate buffer, pH 7.4) followed by freshly prepared
4% paraformaldehyde in 0.1 M sodium phosphate buffer, 0.1
M phosphate buffer (pH 7.4). Brains were removed, postfixed
overnight, gradiently dehydrated with 20 and 30% sucrose in PBS
and frozen at −80◦C. For each animal, six sets of 30-µm-thick
coronal brain sections were cut on Leica cryostat and preserved
in PBS-buffered 50% glycerol at−20◦C until used for subsequent
free-floating immunohistochemistry.
Sections were incubated in 3% H2O2 for 15 min at room
temperature, and rinsed three times with PBS. After blocking
in PBS containing 0.3% Triton X-100 and 5% bovine serum
albumin for 1 h, the sections were then incubated with
primary antibody overnight at 4◦C and followed by incubation
with appropriate secondary antibodies (Vectastain laboratories)
in room temperature. Markers were visualized with 3,3-
diaminobenzidine (DAB), sections were dehydrated and cover
slipped with DPX mountant. Mouse anti-glial fibrillary acidic
protein (GFAP) antibody (EMD Millipore, 1:2000) was used
for staining in this study. The total number of GFAP-positive
astrocytes in CA1 or CA3 region was counted. We also counted
the percentage of GFAP-positive reactive astrocyte, characterized
by hypertrophic cell bodies and intensely stained processes.
Three consecutive sections per brain were analyzed and provided
a single value for each mouse. The images were captured and
analyzed by NIS-Elements AR microscope software and ImageJ
software (NIH).
Neuronal death and degeneration were detected by Nissl
(Cresyl Violet) and Fluoro-Jade C (FJc) staining. Nissl staining
was performed in terms of the manufacturer’s protocol (IHC
WORLD). The Nissl substance (rough endoplasmic reticulum)
appears dark blue due to the staining of ribosomal RNA, giving
the cytoplasm a mottled appearance. These features disappear in
dead neurons. The surround glia cells (small size, weak-stained)
were not counted. Nissl positive pyramidal cells (big size, strong-
stained) were counted in a 250 × 250 µm square applied at the
center of the CA1 and CA3 regions. Three consecutive sections
per brain were analyzed and provided a single value for each
mouse. The data were shown as the normalized percentages. FJc
staining was performed as described in the literature (Schmued
et al., 1997, 2005; Hopkins et al., 2000; Liang et al., 2008), brain
sections were mounted with distilled water onto gelatin coated
slides and dried at 50◦C on slide warmer for 30 min. After
rehydration in 100% ethanol for 5 min, 70% ethanol for 2 min,
and distilled water for 2 min, the sections were oxidized in freshly
prepared 0.06% potassium permanganate for 15 min followed
with rinsing with distilled water for 2 min. The sections were
immersed in 0.001% FJc dissolved in 0.1% acetic acid vehicle
for 10 min and then rinsed three times with distilled water for
1 min. Thereafter, slides were air dried, cleared with xylene and
coverslipped. The FJc positive cells of the CA1 and CA3 sub-
regions of hippocampus were counted with ImageJ software in
each of the three sections per animal. The average of the FJc
positive cells (%) was expressed as percentage of the control.
An observer blind to genotype and treatment performed cell
counting.
Western Blotting
At 24 h after administration of KA (20 mg/kg) or saline,
animals were anesthetized and sacrificed by cervical dislocation.
The hippocampus tissue was harvested immediately and stored
at −80◦C. For tissue lysate preparation, it was homogenized
in RIPA buffer. The samples were centrifuged at 12,000 rpm
for 5 min and supernatant was collected and kept on ice.
Protein concentration was determined using the protein assay
kit from Bio-Rad. Supernatant was separated on 4–15% gradient
SDS-PAGE gels and transferred to nitrocellulose membranes.
The integrated optic density of the immunoreactive bands was
measured and quantified with ImageJ (National Institutes of
Health). Primary antibodies used in this study include rabbit
polyclonal anti-SIRT5 antibody (cell signaling, 1:1000), rabbit
polyclonal anti-GPx antibody (Abcam, 1:1000), rabbit polyclonal
anti-SOD2 antibody (Abcam, 1:2000) and mouse anti-actin
(Millipore, 1:5000). Detection was carried out using horseradish
peroxidase-conjugated anti-mouse, anti-rabbit antibody (GE
Healthcare, 1:2000) and Thermo Scientific Pierce ECL Western
Blotting Substrate.
Quantitative Real-Time PCR
At 24 h after KA (20 mg/kg) or saline injection, tissue
from hippocampus was dissected as described above from
SIRT5−/− and WT mice. Total RNA was extracted using
Trizol (Invitrogen) and purified using a RNeasy kit (Qiagen)
according to the Qiagen protocol. After isolation, RNA
(20 ng per sample) was reverse transcribed to cDNA using
SuperScript III RT Reverse Transcriptase (Invitrogen), which
was stored at −20◦C until further analysis. The mRNA levels
were quantified with a quantitative real-time PCR (qPCR)
system (Stratagene Mx4000). Each sample was detected in
triplicate and each experiment was repeated three times.
The following primers for expression analysis were designed
using TaqMan assays (Life Technologies) and NCBI Primer-
Blast: (5′→3′): SIRT5, forward, GCAGACGGGTTGTGGTCAT;
reverse, CGATGCAACTCGTCAATGTTCT.
Statistical Analysis
All quantitative data were performed using Prism software
(GraphPad Software). The number of independent experiments
is stated in the figure or figure legend. Survival was assessed
using Kaplan–Meier analysis, and the statistically significant
difference between two groups was determined with the log-
rank test. Data from seizure scoring were analyzed using two-
way analysis of variance (ANOVA) for repeated measurements.
Unless otherwise noted, the comparison only between the
two groups was analyzed using unpaired Student’s t tests,
while multigroup comparisons were carried out using two-way
ANOVA followed by Bonferroni post hoc tests. Results are
expressed as group mean ± SEM and statistical significance was
set at p< 0.05.
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RESULTS
SIRT5 Deficiency Increases Mortality Rate
and Response to KA-Induced Seizures
We first investigated whether SIRT5 affects seizure susceptibility.
SIRT5−/− and WT mice were injected with different dosages of
KA, and the mortality rate and seizure severity were examined.
The Kaplan–Meier survival curves showed that SIRT5 deficiency
significantly increased the mortality (p < 0.05) in 24 h following
KA injection at both lower (20 mg/kg) and higher (25 mg/kg)
dosages (Figures 1A,B). At lower dosage, KA administration
caused enhanced mortality by∼35% of SIRT5−/− mice (n= 19),
in contrast to less than 10% mortality rate of WT mice (n = 23,
Figure 1A). Surprisingly, the mortality of SIRT5−/− mice rose
to 75% (n = 8) during 24 h following KA administration at
higher dosage compared to 12.5% for WT control mice (n = 8,
Figure 1B), further emphasizing the importance of SIRT5 and its
regulation in this process.
To learn whether SIRT5 deficiency affects behavioral seizures,
the seizure responses to KA (20 mg/kg) in SIRT5−/− mice and
control mice were evaluated by trained experimenter blinded
to genotype according to reference descriptions (Ben-Ari et al.,
1981; Yang et al., 1997). During 2 h after KA injection, mice
of both genotypes developed acute, yet transient seizures that
peaked between 40–80 min after KA injection and then decayed
slowly (Figure 1C). With time, the majority of SIRT5−/− mice
underwent much more severe seizures (p < 0.001), whereas
WT mice were less likely to suffer from seizures. In addition
to seizure scores, seizure severity was calculated by integrating
individual scores of each mouse over the experiment period
(Giménez-Cassina et al., 2012). This method incorporates the
seizure severity of mice that died in 2 h after KA injection,
FIGURE 1 | Sirtuin 5 (SIRT5) deficiency increases mortality and seizure severity. Kaplan–Meier survival curves show statistically significant difference
(P < 0.05) in survival between SIRT5−/− and control mice over 24 h following kainate (KA) injection at the dosage of both 20 mg/kg (A) and 25 mg/kg (B). KA (20
mg/kg): SIRT5−/− : n = 23, WT: n = 19; KA (25 mg/kg): SIRT5−/− : n = 8, WT: n = 8. Survival was assessed using Kaplan–Meier analysis, and the statistically
significant difference between two groups was determined with the log-rank test. (C) Seizure response over time in SIRT5−/− (n = 19) and WT (n = 19) mice
following KA injection (20 mg/kg). For each 20-min interval, the highest level of seizure activity was scored using seizure scale. With time, seizures were more severe
in SIRT5−/− mice. Data from seizure scoring were analyzed using two-way analysis of variance (ANOVA) for repeated measurements. (D) Integrated seizure severity
of the cohort of mice. SIRT5−/− : n = 23, WT: n = 19. The comparison was analyzed using unpaired Student’s t tests. Data in (C,D) are presented as mean ± SEM.
*p < 0.05; **p < 0.01; ***p < 0.001; n.s., non-significant.
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which can better reflect the whole picture. In contrast, SIRT5−/−
mice exhibited dramatic increase in both maximum (p < 0.01)
and average (p < 0.001) seizure severity (Figure 1D). Together,
our findings indicate that SIRT5 deficiency strikingly increases
susceptibility to KA-induced epileptic seizures by using different
dosages of KA injection and different analyses of seizure severity.
Based on these results, mice treated with KA (20mg/kg) or Saline
were used for the following experiments.
SIRT5 Deficiency Increases KA-Induced
Hippocampal Neurodegeneration
KA-induced seizures are often associated with complex
histological damages in hippocampus and other cerebral
areas. In the hippocampus, delayed neuronal cell death of the
CA1 and CA3 pyramidal neurons becomes apparent until
3–5 days in mice after KA injection (Kinoshita et al., 2012). To
determine the role of SIRT5 in KA-induced neurodegeneration
FIGURE 2 | KA-induced hippocampal neuronal death and degeneration is dramatically reduced in SIRT5−/− mice. All hippocampal slices were collected
from WT and SIRT5−/− mice 5 days after KA administration, and Nissl staining was performed for neuronal damage evaluation. (A) Representative hippocampus,
CA1 and CA3 images from WT+Sal, SIRT5−/−+Sal, WT+KA, SIRT5−/−+KA animals. (B) Quantification was performed by counting the number of Nissl positive
neurons (Sal groups: n = 4; KA groups: n = 6) in CA1 (B) and CA3 (C) regions. The data were carried out using two-way ANOVA followed by Bonferroni post hoc
tests. Data are presented as mean ± SEM. *p < 0.05; **p < 0.01; n.s., non-significant; Sal, saline; KA, Kainate; WT, wild-type. Scale bar, 500 µm (A, top panel) and
100 µm (A, in hippocampal CA1 and CA3 regions).
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 June 2016 | Volume 10 | Article 171
Li and Liu SIRT5 Deficiency Enhances Seizure Susceptibility
and whether SIRT5 deficiency may add this vulnerability,
hippocampal neuronal death and degeneration of SIRT5−/−
and WT mice at 5 days after KA exposure, including those with
similar seizure scores, were examined by Nissl staining and FJc
staining of nearby sections (Figures 2, 3).
As shown in Figure 2A, under normal condition, no
gross structural abnormalities were detected in SIRT5−/− mice
compared with WT control mice in all hippocampal regions.
Severe neuronal death was observed in the hippocampal CA1
(54.2 ± 11.8%, 95 ± 21) and CA3 regions (60.5 ± 13.1%,
131 ± 29) of SIRT5−/− mice at 5 days after KA administration,
whereas WT mice exhibited comparably much less neuronal
damage (CA1: 87.9± 3.7%, 155± 7; CA3: 89.7± 2.9%, 196± 6),
which indicated that SIRT5 deficiency caused remarkably more
severe hippocampal neuron degeneration compared with WT
controls (p < 0.05, Figures 2A–C). Interestingly, no apparent
FIGURE 3 | SIRT5 deficiency exacerbates neurodegeneration in the
hippocampal CA1 and CA3 regions after KA administration. (A)
Representative sections of Fluoro-Jade C (FJc) staining in hippocampus of WT
and SIRT5−/− mice are shown 5 days after KA administration. Significantly
increased FJc-positive neurons were detected in the CA1 and CA3 regions of
SIRT5−/− mice compared to WT controls. (B) Quantitative analysis of FJc
fluorescence in hippocampal subregions 5 days after KA (n = 6 rats per
group). The comparison was analyzed using unpaired Student’s t tests. Data
are presented as mean ± SEM. *p < 0.05. Scale bar, 50 µm.
neuronal loss was observed in dentate gyrus (DG) region
in both genotypes, which was consistent with the previous
report concerning the affected brain areas in rodent seizure
model triggered by systemic KA administration (Wang et al.,
2005). These morphological findings suggested neuroprotective
effect of SIRT5 against KA-induced delayed cell death in
hippocampus.
To further confirm the above assessment of severity of
hippocampal neurodegeneration, we stained dying neurons in
the hippocampus with FJc. Figure 3 shows the representative
images of FJc staining in the hippocampus of SIRT5−/− and WT
control brains 5 days after KA administration. As expected, the
FJc positive cells are predominantly confined to the pyramidal
cell layers of the CA1 and CA3 regions, which are consistent
with neuronal loss by Nissl staining. The dentate granule layer
was not stained at all (not shown). This pattern of FJc staining is
also consistent with that of neuronal death in hippocampus. In
both CA1 and CA3, the average numbers of FJc positive cells in
SIRT5−/− group are significantly increased than the value for the
WT control group (p< 0.05).
SIRT 5 Deficiency Exacerbates Reactive
Astrogliosis in Hippocampus
Reactive gliosis, the morphological and biochemical changes
in astrocytes, is often a prominent feature of human epilepsy
and most animal models of recurrent seizures. To evaluate the
effect of SIRT5 deficiency on hippocampal reactive astrogliosis
following KA-induced injury, we investigated the phenotypes
of astrocyte by immunostaining of GFAP, an astrocyte marker.
In the normal condition (Figure 4A, left panels), astrocytes
contiguously tiled the entire hippocampus and exhibited a
regular distribution pattern in WT mice, most of which showed
nonreactive condition (resting astrocyte) with small soma
and 3–6 fine processes. No gross alteration was detected in
SIRT5−/− mice. Immunohistochemical analysis showed that KA
exposure elicited a dramatic increase of GFAP immunoreactivity
in the number and morphology change throughout the
hippocampus at 5 days after KA administration, particularly
prominent in the CA1 and CA3 areas; most astrocytes showed
reactive phenotype characterized by hypertrophic cell bodies
and intensely stained processes. SIRT5 deficiency apparently
exacerbated KA-induced reactive astrogliosis (Figure 4A, right
panels) in the CA1 and CA3 regions but not in the DG
region. In addition, a few degenerated astrocytes with breakdown
cell bodies were found in SIRT5−/− mice but not in WT
mice. Interestingly, KA exposure triggered apparent loss of
astrocytes in the CA3 pyramidal layer, especially in SIRT5−/−
mice, which is consistent with previous report (Gualtieri et al.,
2012).
Quantitative analysis showed that there was a slight increase
in the total numbers of GFAP positive astrocytes in hippocampal
CA1, CA3 and DG regions in both SIRT5−/− and WT mice
(Figure 4B, P > 0.05). Notably, a much higher percentage of
reactive astrocytes induced by KA exposure was detected in the
hippocampus, especially that was more prominent in the CA1
and CA3 regions in SIR5−/− mice compared to WT controls
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FIGURE 4 | SIRT5 deficiency exacerbates reactive astrogliosis in the hippocampus of mice after KA administration. (A) Compared to nonreactive
astrocytes in the control hippocampus, many astrocytes in the hippocampal CA1 and CA3 regions of KA administered mice were reactive and showed greater glial
fibrillary acidic protein (GFAP) immunoreactivity, especially in SIRT5−/− mice. Interestingly, the astrocyte reactivation in hippocampal dentate gyrus (DG) is not
dramatically altered, comparable to that in the CA1 and CA3 regions. Quantification of the (B) total numbers of GFAP positive astrocytes and (C) the percentages of
reactive astrocytes in different regions of whole hippocampus (n = 6 per group). The data were carried out using two-way ANOVA followed by Bonferroni post hoc
tests. Data are presented as mean ± SEM. *p < 0.05, **p < 0.01. n.s., non-significant. Scale bar, 500 µm (A, top panel) and 100 µm (A, in hippocampal CA1, CA3
and DG regions).
(Figure 4C, P < 0.05). In order to avoid potential bias, two
independent analyses were performed by two trained observers
blinded to genotype and treatment. In summary, these results
indicate that SIRT5 deficiency exacerbates KA-induced reactive
astrogliosis in the hippocampus.
KA Exposure Results in the Increased
Expression of SIRT5 in Hippocampus
SIRT5 expression is essential for maintaining proper
mitochondrial function, which is required for metabolic
homeostasis and regulation of the activity of multiple metabolic
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FIGURE 5 | Expression level of SIRT5 in hippocampus in 24 h following KA administration. SIRT 5 expression levels were assessed by quantified with a
quantitative real-time PCR (qPCR) and western blot. (A) SIRT 5 mRNA is dramatically upregulated in hippocampus of WT mice in 24 h after KA exposure. mRNA
levels are expressed as a ratio to 18 S rRNA expression and normalized to baseline controls. Mean ± SEM, n = 4–5 per group. ***p < 0.001. (B) SIRT5 protein
expression levels in 24 h after KA exposure. n = 4–5 per group. Although the total SIRT5 protein level was not notably altered (C), the ratio of SIRT5 protein to
VDAC1, a mitochondrial marker, was significantly increased 24 h after KA exposure (D). The comparison was analyzed using unpaired Student’s t tests.
Mean ± SEM, n = 4–5 per group. *p < 0.05.
enzymes (Wallace, 2005). Next, we evaluated the impact of
KA exposure on hippocampal SIRT5 expression. The mRNA
and protein levels of SIRT5 were measured at 24 h following
KA exposure (Figure 5). QPCR showed that SIRT5 mRNA
expression level was more than 2.5 folds higher in 24 h after
KA exposure (Figure 5A). Interestingly, Western Blot results
demonstrated that the ratio of SIRT5 protein to actin was not
obviously altered, but the relative ratio of SIRT5 protein to
VDAC1/Porin, an outer membrane mitochondrial protein as
mitochondria loading control, was significantly increased at 24 h
after KA exposure (Figures 5B–D).
SIRT5 Deficiency does not Affect the
Decline of Mitochondrial ROS Scavenging
Capacity in Hippocampus Damaged by KA
Mitochondrial oxidative stress is emerging as a key factor
that not only results from seizures, but might also contribute
to epileptogenesis. To evaluate whether SIRT5 deficiency
exacerbating KA-induced behavioral seizures and degeneration
is associated with antioxidant capacity, we examined the
expression levels of SOD2 and GPx in the hippocampus of
mice by Western Blot (Figure 6). Our results showed that
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FIGURE 6 | SIRT5 deficiency does not affect the reduction of SOD2 and GPx proteins expression levels derived by KA exposure. The effect of SIRT5
deficiency on protein expression levels of SOD2 and GPx induced by KA exposure: representative Western blot image showing decreased protein levels of SOD2 (A)
and GPx (C) in 24 h in the hippocampus of SIRT5−/− and WT mice exposure to KA. Densitometry analysis of SOD2 and GPx are shown in (B,D). The data were
carried out using two-way ANOVA followed by Bonferroni post hoc tests. Data are expressed as means ± SEM from n = 4–5 per group. *p < 0.05, **p < 0.01. n.s.,
non-significant. SOD2, superoxide dismutase 2; GPx, glutathione peroxidase.
hippocampal SOD2 and GPx expression levels remarkably
decreased at 24 h after KA exposure in both SIRT5−/− and WT
mice. However, to our surprise, at this time point in the present
study, the declines of both enzymes triggered by KA were not
significantly affected by SIRT5 deficiency. These data revealed
that SIRT5 might contribute very little to preserve mitochondrial
antioxidant capacity via SOD2 and GPx from oxidative injury
caused by KA.
DISCUSSION
In rodents, systemic administration of KA can elicit sustained
epileptic activity in the hippocampus. The animals exhibit
recurrent behavioral seizures and progressive neuronal death,
which provides a well-characterized model of neurodegenerative
diseases (Wang et al., 2005; Shin et al., 2011; Zhang and
Zhu, 2011; Zheng et al., 2011; Curia et al., 2014). The
neurodegeneration occurs in adult limbic circuit, particularly in
the CA1 and CA3 areas of hippocampus in rodents following
systemic injection of KA, and this neuronal vulnerability
is related to the selective distribution of the glutamate
receptors (AMPARs/KARs) in hippocampus (Vincent and
Mulle, 2009; Zheng et al., 2011; Kinoshita et al., 2012).
Glutamate excitotoxicity has close synergistic interactions
with oxidative stress and mitochondrial dysfunction, which
contributes to KA-induced seizure and neuronal impairment
and death in vulnerable brain regions (Novelli et al., 1988).
Increasing evidences indicate that the ROS overproduction-
induced oxidative stress results from glutamate medicated
excitotoxicity (Löscher, 2002; Wang et al., 2005; Giardina and
Gasior, 2009). Astrocytic activation and proliferation is the other
characteristic of KA-induced brain damage, which is prominent
in epilepsy.
Mitochondrial SIRT5 has been considered as an important
functional modulator of mitochondria, which contribute to
ageing and neurodegenerative diseases (He et al., 2012; Sack and
Finkel, 2012; Osborne et al., 2014). Previous studies indicated
that SIRT5 can substantially modulate neuronal excitation
(Rardin et al., 2013; Buler et al., 2014; Kumar and Lombard,
2015; Polletta et al., 2015). This led us to hypothesize that SIRT5
may also influence neuronal excitability and consequently, the
severity of seizures induced by chemoconvulsants. To test this
hypothesis, we used the chemical convulsant agent KA to induce
acute seizures via activating excitatory glutamate receptors
(Contractor et al., 2011). The lower dosage of KA (20 mg/kg) was
selected for the experiments to avoid ceiling and floor effects. We
observed that the severity of KA-induced seizure was remarkably
exacerbated in SIRT5−/− mice compared to WT controls, which
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was confirmed by using two different quantification methods.
Significantly, SIRT5−/− mice exhibited much higher mortality
rate to systemic injection of KA in a dosage-dependent manner,
indicating the possible role of SIRT5 and its regulation in
the process of epilepsy. The spontaneous recurrent seizures
are associated with a transient abnormal hypersynchronous
neuronal discharge. Neuronal electrical activity is substantially
integrated with mitochondrial energy metabolism and redox
balance (Zsurka and Kunz, 2015). Our findings demonstrated
that lack of SIRT5 greatly exacerbated KA-induced seizure
severity and mortality of mice, supporting the protective role of
SIRT5 in this seizuremodel. It might present a potential target for
seizure suppression in multiple clinical settings. In addition, it is
noteworthy that SRIT5-null mice are viable and fertile, and lack
gross physiological defects (Nakagawa et al., 2009). Therefore,
pharmacological inhibition of SIRT5 is unlikely to cause obvious
abnormality.
Recurrent seizures are often accompanied by neuronal loss
in human patients and animal models (Chang and Lowenstein,
2003; Curia et al., 2014). The severity of neural damage is
also a key factor in determining the mortality and morbidity
under epilepsy and other pathological conditions. It is well
documented that during acquired epilepsy, structural change or
lesions in the brain including neuronal loss and marked reactive
astrogliosis are often visible. Neuropathological investigations
have repeatedly described a similarity between seizure and
related neuronal alterations characterized by swollen and
disrupted mitochondria. Systemic injection of KA produced
extensive neuronal death, primarily within CA3 and CA1 areas.
The delayed cell death in CA1 appears to be more apoptotic
compared to acute, primarily necrotic neurodegeneration of CA3
and hilar neurons (Gualtieri et al., 2012). Nissl staining has
been widely used as a neuronal death marker. This method
stains Nissl substance in the cytoplasm of neurons, and is
used to highlight important structural features of neurons.
The Nissl substance (rough endoplasmic reticulum) appears
dark blue due to the staining of ribosomal RNA, giving the
cytoplasm a mottled appearance. These features disappear in
dead neurons. As such, we selected Nissl and FJc staining as the
pyramidal neuronal death and degeneration markers to test the
effect of SIRT5 deficiency on KA triggered neurodegeneration
in hippocampal CA1 and CA3 regions. In the present study,
systemic administration of KA produced well-characterized
seizures and selectively hippocampal neurodegeneration, which
was consistent with previous report (Wang et al., 2005; Lee
et al., 2010). Hippocampal pyramidal neurons are singularly
vulnerable to activity dependent cell death following excitotoxic
insults triggered by KA. Previous reports have demonstrated
that FJc, an anionic fluorescein derivative, is a very sensitive
histological staining marker evaluating undergoing degeneration
of cell bodies, axons, dendrites, or terminals (Schmued et al.,
2005). Our results provide compelling evidence that the
two hippocampal subregions showed different vulnerability
profiles to KA-triggered injury. We found that lack of
SIRT5 dramatically exacerbated KA-induced neurodegeneration
in the hippocampal CA1 and CA3 regions, indicating the
potential neuroprotective role of SIRT5 in KA-induced seizure
mice models. The stimulation of KA receptors directly
excites CA3 neurons and increases glutamate efflux. It was
reported that the mechanisms underlying glutamate receptors
and consequent Ca2+-mediated excitotoxicity mainly involve
activation of proteases, mitochondrial Ca2+ overload, excessive
ROS production, and reduced ATP production, all of which act
cooperatively to damage membranes, cellular proteins, DNA and
mitochondrial function, eventually leading to necrosis, apoptosis
or both (Rossi et al., 2007; Khurana et al., 2013). SIRT5 deficiency
may contribute to mitochondrial metabolic dysfunction and the
deficit of mitochondrial antioxidant system.
In healthy brain, astrocytes are organized in a very particular
manner. They send out many fine branches covering synapses
and enwrapping adjacent brain capillaries residing within their
anatomy domains. The functions of astrocytes involve potassium
buffering, interstitial volume regulation, a low interstitial
glutamate concentration control and synchronize neuronal
firing. Astrocytes response to central nervous system (CNS)
damage through reactive astrogliosis, that involves structural and
metabolic changes. Reactive astrogliosis has been considered as
a prominent feature of mesial temporal lobe human epilepsy
and most animal models of recurrent seizures (Wetherington
et al., 2008; Curia et al., 2014; Robel and Sontheimer, 2015;
Sofroniew, 2015; Wilcox et al., 2015; Pekny et al., 2016). The
proliferative response of astrocytes induced by KA exposure
has been reported in 1982 (Murabe et al., 1982), and exhibits
a steady increase from at least 1 or 3 days to 1 month after
KA exposure (Bendotti et al., 2000; Ding et al., 2000). In
our study, the normal organization of astrocytic domain was
disrupted in mice exposed to KA, as revealed by GFAP staining.
These reactive astrocytes exhibited hypertrophic cell bodies and
thick processes. The abnormal ratio of astrocytic volume in the
whole hippocampus was more severe in SIRT5−/− mice exposed
to KA, accompanied by more severe neurodegeneration in
hippocampal CA1 and CA3 regions. In epileptic tissues, reactive
astrocytes may be involved in seizure development via a variety
of specific mechanisms (Wetherington et al., 2008; Robel and
Sontheimer, 2015). The morphological changes occurred during
reactive astrogliosis are paralleled by functional changes. Human
and animal studies have shown the downregulated glutamate
transporter GLT-1 in reactive astrocytes, as well as glutamine
synthetase in epilepsy tissues (Maragakis and Rothstein, 2004).
This may result in an increase of glutamate in astrocytes leading
to its excessive release, triggering synchronized depolarization
of neurons. Reactive astrocytes also exhibit downregulated
inward rectifying K+ channels in temporal lobe epilepsy, thereby
leading to impairment of extracellular K+ clearance, which
is linked to hyperexcitability of neuron (Oberheim et al.,
2008; Sofroniew, 2009). Additionally, the major water channel
(aquaporin-4) loses its polarized location in endfeet of astrocyte
and becomes distributed across the entire cell, potentially leading
to imbalances of both water homeostasis and K+ buffering
(Binder et al., 2012; Nagelhus and Ottersen, 2013; Coulter and
Steinhäuser, 2015). Since the reactive astrogliosis was observed 5
days after KA exposure, the activated astrocyte might contribute
to inflammation that could further promote neuronal cell loss
(Vinet et al., 2016). Together, the data indicates that SIRT5
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deficiency may affect the functional deficit in reactive astrocytes
that play critical roles in regulating seizure susceptibility and
affecting neurodegeneration.
Brain injury caused by seizures and epilepsy is a dynamic
process that comprises multiple factors contributing to neuronal
cell death. Mitochondrial dysfunction and oxidative stress
contribute to neuronal death, which is the key feature of
neurodegeneration (Rowley et al., 2015). KA exposure enhanced
SIRT5mRNA expression level and relatively increased its protein
level in survived mitochondria, which might contribute to the
above beneficial effects against the damage in hippocampus.
It will be more informative to indicate the respective cellular
SIRT5 expression level (neuronal, astrocyte and microglia, etc.)
in the brain. But currently it is not feasible since there is
no excellent commercial SIRT5 antibody that can be used
for double-immunostaining with neuron or glia markers. We
were considering why the KA exposure only affected the
mitochondrial SIRT5 protein expression relatively but not total
protein level reflected by the ratio of Sirtuin5/actin. Since
mitochondria are the primary site of ROS production that makes
them particularly vulnerable to oxidative stress damage, KA
exposure induced injury eventually resulted in mitochondrial
degeneration and loss, which might cover up the increase
of SIRT5 expression triggered by KA exposure. Systemic KA
causes a series of progressively severe and highly stereotyped
behavioral seizures that originate in the hippocampus, which
in turn increases mitochondrial oxidative damage (Lothman
and Collins, 1981; Zeng et al., 2007). Previous studies showed
that SOD2 deficent mice (Sod2−/+) exhibited exacerbated KA-
induced mitochondrial aconitase inactivation and neuronal loss
in hippocampus (Liang and Patel, 2004), and overexpression of
SOD2 in mice attenuated both of these changes, although KA-
induced dramatic reduction of SOD2 and GPx were observed,
we did not find the apparent effect of SIRT5 deficiency on the
decline of these antioxidative enzymes under our paradigm.
The effect of mitochondria in acquired epilepsies, which
account for about 60% of all epilepsies, is important but
less well understood. Although mitochondrial oxidative
stress and dysfunction are associated with inherited
epilepsies, little is known concerning their contributions
in acquired epilepsies. Initial trauma of KA exposure
triggers complex cellular and molecular events, leading
to functional and structural modification in the brain,
which contributes to the pathogenesis of epilepsy and,
as a result, recurrent seizures. Both functional and
pathological defects of mitochondria have been reported in
epileptogenesis (Volmering et al., 2016). Further investigations
are needed to encode the natural property of SIRT5
in mitochondria and their contribution in epilepsy and
neurodegeneration.
In conclusion, the present study shows that SIRT5
deficiency strikingly increased mortality rate and seizure
severity, exacerbated hippocampal neuronal death and
degeneration, and triggered more severe reactive astrogliosis
in mice exposed to KA. We found that the expression of
mitochondrial SIRT5 of injured hippocampus was relatively
up-regulated, indicating its potential contribution to the
comparably increased survival of these cells and its possible
neuroprotective role. SIRT5, to our surprise, did not seem
to apparently alter the decline of antioxidant enzymes SOD2
and GPx in hippocampus caused by KA exposure in our
paradigm. The protective mechanism of SIRT5 on seizures
and cellular degeneration might through different regulatory
mechanism other than antioxidant enzymes SOD2 and GPx,
which we would like to explore in the future experiment. For
the first time we illustrate the role of SIRT5 in KA-induced
mice model, offering a new understanding of roles of SIRT5
in mitochondrial functional regulation and their potential
neuroprotection. These results will enrich our acknowledgment
of the natural property of SIRT5 in health and neurological
diseases.
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